Assessment for Long-Term Cardiovascular Impairment Associated With Trastuzumab Cardiotoxicity in HER2-Positive Breast Cancer Survivors
Clinical trial NCT02615054 · COMPLETED
Trial details
- NCT number
- NCT02615054
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2015-11-18
- Primary completion
- 2024-03-05
- Enrollment
- 58
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.